Activity of exoglycosidases in blood, urine, cerebrospinal fluid, and vitreous humor in individuals who died from ethyl alcohol poisoning.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 Sep 2024
Historique:
received: 09 11 2023
accepted: 19 07 2024
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 30 9 2024
Statut: epublish

Résumé

Lysosomal exoglycosidases, namely α-mannosidase (MAN), α-fucosidase (FUC), β-galactosidase (GAL), and β-glucuronidase (GLU), are of crucial importance in breaking down the oligosaccharide chains of multiple glycoconjugates. Those enzymes liberate monosaccharides from non-reducing ends of oligosaccharide chains. In this study, we have aimed to assess the potential utility of MAN, FUC, GAL, and GLU activities as indicators of ethanol abuse in individuals who died from ethanol intoxication, while also investigating the mechanisms underlying their deaths. The study group comprised 22 fatal ethanol-intoxicated individuals, while the control group included 30 deceased individuals whose body fluids showed no traces of alcohol. We measured the activities (pKat/mL) of MAN, FUC, GAL, and GLU in the supernatants of blood, urine, cerebrospinal fluid as well as vitreous humor. The results indicated significantly lower activities of MAN (p = 0.003), FUC (p = 0.008), GAL (p = 0.014), and GLU (p = 0.004) in the urine of individuals poisoned by ethanol as compared to the control group. Additionally, there was a significantly lower activity of MAN in the vitreous of those affected by ethyl alcohol poisoning (p = 0.016).

Identifiants

pubmed: 39349484
doi: 10.1038/s41598-024-68151-x
pii: 10.1038/s41598-024-68151-x
doi:

Substances chimiques

Ethanol 3K9958V90M
alpha-L-Fucosidase EC 3.2.1.51
Glycoside Hydrolases EC 3.2.1.-
alpha-Mannosidase EC 3.2.1.24
beta-Galactosidase EC 3.2.1.23
Glucuronidase EC 3.2.1.31

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

22739

Informations de copyright

© 2024. The Author(s).

Références

Hendriks, H. F. J. Alcohol and human health: What is the evidence?. Annu. Rev. Food Sci. Technol. 11, 1–21 (2020).
doi: 10.1146/annurev-food-032519-051827 pubmed: 32209032
Peacock, A. et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction 113, 1905–1926 (2018).
doi: 10.1111/add.14234 pubmed: 29749059
Witkiewitz, K., Litten, R. Z. & Leggio, L. Advances in the science and treatment of alcohol use disorder. Sci. Adv. 5, eaax4043 (2019).
doi: 10.1126/sciadv.aax4043 pubmed: 31579824 pmcid: 6760932
Kramer, J. et al. Mechanisms of alcohol addiction: Bridging human and animal studies. Alcohol Alcohol. 55, 603–607 (2020).
doi: 10.1093/alcalc/agaa068 pubmed: 32781467 pmcid: 7576503
Ilhan, M. N. & Yapar, D. Alcohol consumption and alcohol policy. Turk. J. Med. Sci. 50, 1197–1202 (2020).
doi: 10.3906/sag-2002-237 pubmed: 32421277 pmcid: 7491269
Nutt, D. et al. Alcohol and the brain. Nutrients 13, 3938 (2021).
doi: 10.3390/nu13113938 pubmed: 34836193 pmcid: 8625009
Roerecke, M. Alcohol’s impact on the cardiovascular system. Nutrients 13, 3419 (2021).
doi: 10.3390/nu13103419 pubmed: 34684419 pmcid: 8540436
Petersen, O. H. Different effects of alcohol on the liver and the pancreas. Funct. (Oxford Engl.) 2, zqab008 (2021).
Yu, J.-T. et al. DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-α in alcohol-induced kidney injury. Pharmacol. Res. 163, 105286 (2021).
doi: 10.1016/j.phrs.2020.105286 pubmed: 33157234
Hammoud, N. & Jimenez-Shahed, J. Chronic neurologic effects of alcohol. Clin. Liver Dis. 23, 141–155 (2019).
doi: 10.1016/j.cld.2018.09.010 pubmed: 30454828
Calleja-Conde, J. et al. The immune system through the lens of alcohol intake and gut microbiota. Int. J. Mol. Sci. 22, 7485 (2021).
doi: 10.3390/ijms22147485 pubmed: 34299105 pmcid: 8303153
Sorkina, O., Zaitseva, O. & Khudyakov, A. The effect of long-term alcohol intoxication on the morphological structures and enzymatic activity of rat salivary glands. Alcohol 99, 23–33 (2022).
doi: 10.1016/j.alcohol.2021.11.006 pubmed: 34883230
Rachdaoui, N. & Sarkar, D. K. Pathophysiology of the effects of alcohol abuse on the endocrine system. Alcohol Res. 38, 255–276 (2017).
pubmed: 28988577 pmcid: 5513689
Birková, A., Hubková, B., Čižmárová, B. & Bolerázska, B. Current view on the mechanisms of alcohol-mediated toxicity. Int. J. Mol. Sci. 22, 9686 (2021).
doi: 10.3390/ijms22189686 pubmed: 34575850 pmcid: 8472195
Varga, Z. V., Matyas, C., Paloczi, J. & Pacher, P. Alcohol misuse and kidney injury: Epidemiological evidence and potential mechanisms. Alcohol Res. 38, 283–288 (2017).
pubmed: 28988579 pmcid: 5513691
Doremus-Fitzwater, T. L., Paniccia, J. E., Gano, A., Vore, A. S. & Deak, T. Differential effects of acute versus chronic stress on ethanol sensitivity: Evidence for interactions on both behavioral and neuroimmune outcomes. Brain Behav. Immun. 70, 141–156 (2018).
doi: 10.1016/j.bbi.2018.02.009 pubmed: 29458194 pmcid: 5953812
Waszkiewicz, N. et al. Salivary exoglycosidases as markers of alcohol dependence. Alcohol Alcohol. 49, 409–416 (2014).
doi: 10.1093/alcalc/agu005 pubmed: 24585093
Yamauchi, M. et al. Urinary level of L-fucose as a marker of alcoholic liver disease. Alcohol. Clin. Exp. Res. 17, 268–271 (1993).
doi: 10.1111/j.1530-0277.1993.tb00761.x pubmed: 8488966
Wehr, H., Czartoryska, B., Górska, D. & Matsumoto, H. Serum beta-hexosaminidase and alpha-mannosidase activities as markers of alcohol abuse. Alcohol. Clin. Exp. Res. 15, 13–15 (1991).
doi: 10.1111/j.1530-0277.1991.tb00513.x pubmed: 1673822
Geokas, M. C. & Rinderknecht, H. Plasma arylsulfatase and beta-glucuronidase in acute alcoholism. Clin. Chim. Acta 46, 27–32 (1973).
doi: 10.1016/0009-8981(73)90098-3 pubmed: 4732886
Maciejczyk, M. et al. Do circulating redox biomarkers have diagnostic significance in alcohol-intoxicated people?. Int. J. Mol. Sci. 23, 11808 (2022).
doi: 10.3390/ijms231911808 pubmed: 36233115 pmcid: 9569923
Marciniak, J., Zalewska, A., Popko, J. & Zwierz, K. Optimization of an enzymatic method for the determination of lysosomal N-acetyl-beta-D-hexosaminidase and beta-glucuronidase in synovial fluid. Clin. Chem. Lab. Med. 44, 933–937 (2006).
doi: 10.1515/CCLM.2006.177 pubmed: 16879057
Chojnowska, S. et al. Determination of lysosomal exoglycosidases in human saliva. Acta Biochim. Pol. 61, 85–90 (2014).
doi: 10.18388/abp.2014_1927 pubmed: 24644545
Chojnowska, S. et al. Optimization of the method for α-l-fucosidase, β-d-galactosidase and β-d-glucuronidase determination in serum from hemolyzed blood. Adv. Med. Sci. 63, 306–311 (2018).
doi: 10.1016/j.advms.2018.04.005 pubmed: 29885630
Ptaszyńska-Sarosiek, I. et al. The activity of N-acetyl-β-hexosaminidase in the blood, urine, cerebrospinal fluid and vitreous humor died people due to alcohol intoxication. J. Clin. Med. 9, 3636 (2020).
doi: 10.3390/jcm9113636 pubmed: 33198185 pmcid: 7696024
Trela, F. M. Ethanol distribution in body fluids in the human from a forensic medicine viewpoint. Prepared as an initial study. Blutalkohol 26, 305–318 (1989).
pubmed: 2803707
Kurzejamska-Parafiniuk, M., Wolski, S., Mikołajczak, A., Stańczyk, J. & Czechowski, W. Comparative tests of ethyl alcohol concentrations in blood, vitreous body of an eye and urine collected from a corpse. Ann. Acad. Med. Stetin 53(Suppl 2), 166–9 (2007).
pubmed: 20143702
Andresen-Streichert, H., Müller, A., Glahn, A., Skopp, G. & Sterneck, M. Alcohol biomarkers in clinical and forensic contexts. Dtsch. Arztebl. Int. 115, 309–315 (2018).
pubmed: 29807559 pmcid: 5987059
Niemelä, O. Biomarkers in alcoholism. Clin. Chim. Acta 377, 39–49 (2007).
doi: 10.1016/j.cca.2006.08.035 pubmed: 17045579
Musshoff, F. Chromatographic methods for the determination of markers of chronic and acute alcohol consumption. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 781, 457–80 (2002).
doi: 10.1016/S1570-0232(02)00691-8
Sommers, M. S. Measurement of alcohol consumption: Issues and challenges. Annu. Rev. Nurs. Res. 23, 27–64 (2005).
doi: 10.1891/0739-6686.23.1.27 pubmed: 16350762
Swift, R. Direct measurement of alcohol and its metabolites. Addiction 98(Suppl 2), 73–80 (2003).
doi: 10.1046/j.1359-6357.2003.00605.x pubmed: 14984244
Helander, A., Eriksson, C. J. P., WHO/ISBRA Study on State and Trait Markers ofAlcohol Use and Dependence Investigators. Laboratory tests for acute alcohol consumption: Results of the WHO/ISBRA study on state and trait markers of alcohol use and dependence. Alcohol. Clin. Exp. Res. 26, 1070–7 (2002).
doi: 10.1111/j.1530-0277.2002.tb02641.x pubmed: 12170117
Waszkiewicz, N. et al. Serum exoglycosidases in children and adolescents with harmful alcohol use. J. Addict. Med. 12, 329–335 (2018).
doi: 10.1097/ADM.0000000000000411 pubmed: 29570478
Pantoja, A., Scott, B. K. & Peterson, C. M. Studies of urine-associated acetaldehyde as a marker for alcohol intake in mice. Alcohol 8, 439–441 (1991).
doi: 10.1016/S0741-8329(91)90068-8 pubmed: 1781920
Tsukamoto, S. et al. Concentrations of blood and urine ethanol, acetaldehyde, acetate and acetone during experimental hangover in volunteers. Arukoru Kenkyuto. Yakubutsu Ison. 26, 500–510 (1991).
pubmed: 1785958
Waszkiewicz, N. et al. Alcohol abuse and glycoconjugate metabolism. Folia Histochem. Cytobiol. 50, 1–11 (2012).
doi: 10.5603/FHC.2012.0001 pubmed: 22532130
Eiser, A. R. The effects of alcohol on renal function and excretion. Alcohol. Clin. Exp. Res. 11, 127–138 (1987).
doi: 10.1111/j.1530-0277.1987.tb01275.x pubmed: 3296829

Auteurs

Iwona Ptaszyńska-Sarosiek (I)

Department of Forensic Medicine, Medical University of Bialystok, Waszyngtona 13, 15-269, Białystok, Poland. i.sarosiek@wp.pl.

Agnieszka Kułak-Bejda (A)

Department of Psychiatry, Medical University of Bialystok, Wołodyjowskiego 2, 15-272, Białystok, Poland.

Anna Niemcunowicz-Janica (A)

Department of Forensic Medicine, Medical University of Bialystok, Waszyngtona 13, 15-269, Białystok, Poland.

Napoleon Waszkiewicz (N)

Department of Psychiatry, Medical University of Bialystok, Wołodyjowskiego 2, 15-272, Białystok, Poland.

Urszula Cwalina (U)

Department of Statistics and Medical Informatics, Medical University of Bialystok, Szpitalna 37, 15-295, Białystok, Poland.

Miłosz Nesterowicz (M)

Department of Forensic Medicine, Medical University of Bialystok, Waszyngtona 13, 15-269, Białystok, Poland.

Jurgita Stasiūnienė (J)

Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio G. 21, 03101, Vilnius, Lithuania.

Sławomir Dariusz Szajda (SD)

Department of Emergency Medical Service, University of Warmia and Mazury in Olsztyn, Oczapowskiego 2, 10-719, Olsztyn, Poland.

Sylwia Chojnowska (S)

Faculty of Health Sciences, University of Lomza, Akademicka 14, 18-400, Łomża, Poland.

Michał Szeremeta (M)

Department of Forensic Medicine, Medical University of Bialystok, Waszyngtona 13, 15-269, Białystok, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH